preDiCT

Many drugs fail to reach the market because of side effects on the heart. The principal objective of this proposal is to create an advanced computational technology for in silico assessment of the efficacy and safety of specific drugs [ICT-2007.5.3(c) (3)], i.e. an open environment comprising validated computational models, tools and numerical methods that will enable simulations of drug actions on the electrophysiology of the human heart.

Such simulations will involve modelling of drug interactions at the molecular and cellular level, will extend current technology to enable prediction of the effects of those interactions on the dynamics of the whole heart, and will lead to an understanding of how genetic factors can be used to assess patient-specific risk profiles. This requires a multi-level systems approach, based on multi-scale, multi-physics methods, including computations on adaptive spatial grids and multi-grid time integration. Computations on realistic models at appropriate spatial and temporal scales are currently not feasible, so we will investigate new algorithms and their implementation on high-performance platforms, including a new generation of petaflop computers, to achieve 'faster than real-time' simulation.

These tools form part of the infrastructure required to simulate the physiology of major organ systems, thereby contributing to the goal of creating the Virtual Physiological Human (VPH) [ICT-2007.5.3]. The balanced team in this project, including founders of the Human Physiome Project, has decades of experience in the experimental study and modelling of the electrophysiology and mechanics of the heart, while pharmaceutical industry partners bring deep understanding of the mechanisms of drug actions. The results will demonstrate the value of the VPH initiative to fundamental scientific understanding of the heart, with major economic and clinical impacts through accelerated drug development, approval and use.

For further information, please visit:
http://www.vph-predict.eu

Project co-ordinator:
The Chancellor, Master and Scholars of the University of Oxford

Partners:

  • F. Hoffmann-La Roche AG
  • Szegedi Tudományegyetem
  • Fujitsu Laboratories of Europe Limited
  • Glaxo Smithkline Research and Development
  • Universidad Politécnica de Valencia
  • Centro di Ricerca, Sviluppo e Studi Superiori in Sardegna
  • Novartis Pharma AG
  • Aureus Pharma SA

Timetable: from 06/2008 – to 05/2011

Total cost: € 5.545.692

EC funding: € 4.100.000

Programme Acronym: FP7-ICT

Subprogramme Area: Virtual physiological human

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

MSD Innovation Factory Selects 3 Compani…

Throughout the MSD Innovation Factory, MSD launched 7 health-related challenges to award the three most outstanding solutions. Blendarsys, Symptoma and Grupo Pulso are the winners out of 100 proposals. The...

Using Virtual Reality to Identify Brain …

Virtual reality is helping neuroscientists at the University of California, Davis, get new insight into how different brain areas assemble memories in context. In a study published Jan. 18 in...

People with Tetraplegia Gain Rapid Use o…

For a brain-computer interface (BCI) to be truly useful for a person with tetraplegia, it should be ready whenever it's needed, with minimal expert intervention, including the very first time...

East Lancashire Hospitals Chooses Cerner…

East Lancashire Hospitals NHS Trust (ELHT) has chosen global health information technology leader Cerner as its Preferred Supplier of a new clinical information system that will help to improve the...

Hamlyn Centre Announces Grant from Bill …

The Hamlyn Centre at Imperial College London today announces the award of a grant from the Bill & Melinda Gates Foundation, to accelerate research into new integrated technology systems for...

Philips Debuts Fully Integrated Suite o…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system consists of bedside...

Liverpool Awards Contract to Docobo

One of the best-known users of telehealth in England has awarded a contract to Docobo to significantly expand its service over the next three years. NHS Liverpool Clinical Commissioning Group...

Augmented Reality System Lets Doctors Se…

New technology is bringing the power of augmented reality into clinical practice. The system, called ProjectDR, allows medical images such as CT scans and MRI data to be displayed directly...

Assessing Health Technology in the EU: C…

European Commission has put forward a proposal to boost cooperation amongst EU Member States for assessing health technology. Greater transparency will empower patients, by ensuring their access to information on...

ProEmpower Releases Call for Tenders to …

The ProEmpower procurers are looking for a diabetes management solution that will tackle the unmet needs in the current treatment of diabetes such as the fragmentation in today’s healthcare systems...

Biosensors Will Be Inexpensive, Do More…

When it comes to biometric sensors, human skin isn't an ally. It's an obstacle. The University of Cincinnati is developing cutting-edge methods to overcome this barrier without compromising the skin...